Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2008 8
2009 4
2010 2
2011 7
2012 4
2013 7
2014 8
2015 4
2016 16
2017 9
2018 15
2019 14
2020 11
2021 21
2022 18
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Neuromodulation in epilepsy: state-of-the-art approved therapies.
Ryvlin P, Rheims S, Hirsch LJ, Sokolov A, Jehi L. Ryvlin P, et al. Among authors: rheims s. Lancet Neurol. 2021 Dec;20(12):1038-1047. doi: 10.1016/S1474-4422(21)00300-8. Epub 2021 Oct 25. Lancet Neurol. 2021. PMID: 34710360 Review.
Mapping Lesion-Related Epilepsy to a Human Brain Network.
Schaper FLWVJ, Nordberg J, Cohen AL, Lin C, Hsu J, Horn A, Ferguson MA, Siddiqi SH, Drew W, Soussand L, Winkler AM, Simó M, Bruna J, Rheims S, Guenot M, Bucci M, Nummenmaa L, Staals J, Colon AJ, Ackermans L, Bubrick EJ, Peters JM, Wu O, Rost NS, Grafman J, Blumenfeld H, Temel Y, Rouhl RPW, Joutsa J, Fox MD. Schaper FLWVJ, et al. Among authors: rheims s. JAMA Neurol. 2023 Sep 1;80(9):891-902. doi: 10.1001/jamaneurol.2023.1988. JAMA Neurol. 2023. PMID: 37399040 Free PMC article.
Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial.
Peter-Derex L, Philippeau F, Garnier P, André-Obadia N, Boulogne S, Catenoix H, Convers P, Mazzola L, Gouttard M, Esteban M, Fontaine J, Mechtouff L, Ong E, Cho TH, Nighoghossian N, Perreton N, Termoz A, Haesebaert J, Schott AM, Rabilloud M, Pivot C, Dhelens C, Filip A, Berthezène Y, Rheims S, Boutitie F, Derex L. Peter-Derex L, et al. Among authors: rheims s. Lancet Neurol. 2022 Sep;21(9):781-791. doi: 10.1016/S1474-4422(22)00235-6. Lancet Neurol. 2022. PMID: 35963261 Clinical Trial.
[Management of drug-resistant epilepsy].
Loizon M, Rheims S. Loizon M, et al. Among authors: rheims s. Presse Med. 2018 Mar;47(3):234-242. doi: 10.1016/j.lpm.2017.11.012. Epub 2018 Mar 8. Presse Med. 2018. PMID: 29525516 Review. French.
CB2 receptor in the CNS: From immune and neuronal modulation to behavior.
Grabon W, Rheims S, Smith J, Bodennec J, Belmeguenai A, Bezin L. Grabon W, et al. Among authors: rheims s. Neurosci Biobehav Rev. 2023 Jul;150:105226. doi: 10.1016/j.neubiorev.2023.105226. Epub 2023 May 8. Neurosci Biobehav Rev. 2023. PMID: 37164044 Review.
Author Response.
Rheims S. Rheims S. Neurology. 2016 Mar 22;86(12):1171. Neurology. 2016. PMID: 27447019 No abstract available.
152 results